{"organizations": [], "uuid": "32f26633f5a5b3815b998d1a8c3c50e641a5b287", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180221.html", "section_title": "Archive News &amp; Video for Wednesday, 21 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-neogenomics-reports-q4-adjusted-ep/brief-neogenomics-reports-q4-adjusted-eps-of-0-05-idUSASB0C6M8", "country": "US", "domain_rank": 408, "title": "BRIEF-NeoGenomics Reports Q4 Adjusted EPS Of $0.05", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.062, "site_type": "news", "published": "2018-02-21T20:10:00.000+02:00", "replies_count": 0, "uuid": "32f26633f5a5b3815b998d1a8c3c50e641a5b287"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-neogenomics-reports-q4-adjusted-ep/brief-neogenomics-reports-q4-adjusted-eps-of-0-05-idUSASB0C6M8", "ord_in_thread": 0, "title": "BRIEF-NeoGenomics Reports Q4 Adjusted EPS Of $0.05", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters) - neogenomics inc", "sentiment": "neutral"}, {"name": "ebitda", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 21 (Reuters) - NeoGenomics Inc:\n* NEOGENOMICS REPORTS REVENUE OF $67.8 MILLION ON 18.7% CLINICAL VOLUME GROWTH AND $10.5 MILLION OF ADJUSTED EBITDA IN THE FOURTH QUARTER OF 2017\n* Q4 ADJUSTED EARNINGS PER SHARE $0.05 * Q4 REVENUE ROSE 12.1 PERCENT TO $67.8 MILLION * SEES FY 2018 REVENUE $260 MILLION TO $272 MILLION * SEES 2018 ‍GAAP DILUTED EPS TO BE A LOSS OF $0.13 TO $0.08 PER SHARE​\n* SEES 2018 ‍ADJUSTED DILUTED EPS TO BE $0.15 - $0.20 PER SHARE​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-21T20:10:00.000+02:00", "crawled": "2018-02-22T17:58:47.029+02:00", "highlightTitle": ""}